524.38

0.01% 0.20

Thermo Fisher Scientific Inc (TMO)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt TMO? Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$524.58

Offen:

$521.74

24-Stunden-Volumen:

555.22K

Relative Volume:

0.24

Marktkapitalisierung:

$198.11B

Einnahmen:

$43.21B

Nettoeinkommen (Verlust:

$6.58B

KGV:

30.35

EPS:

17.2769

Netto-Cashflow:

$6.17B

1W Leistung:

-2.69%

1M Leistung:

+9.42%

6M Leistung:

+16.76%

1J Leistung:

-13.11%

1-Tages-Spanne:

$519.45

$526.52

1-Wochen-Bereich:

$519.45

$549.26

52-Wochen-Spanne:

$385.46

$610.97

Thermo Fisher Scientific Inc Stock (TMO) Company Profile

Firmenname

Thermo Fisher Scientific Inc

Sektor

Healthcare (1146)

Branche

Diagnostics & Research (52)

Telefon

(781) 622-1000

Adresse

168 THIRD AVENUE, WALTHAM, MA

Mitarbeiter

125,000

Twitter

@thermofisher

Nächster Verdiensttermin

2025-07-23

Neueste SEC-Einreichungen

TMO's Discussions on Twitter

Vergleichen Sie TMO mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TMO Thermo Fisher Scientific Inc	524.64	198.09B	43.21B	6.58B	6.17B	17.28
DHR Danaher Corp	205.34	144.97B	24.01B	3.41B	4.86B	4.7082
IDXX Idexx Laboratories Inc	633.29	49.29B	4.04B	985.66M	774.34M	12.01
A Agilent Technologies Inc	138.03	38.73B	6.79B	1.22B	1.09B	4.2644
IQV Iqvia Holdings Inc	204.44	33.69B	15.70B	1.24B	2.01B	6.9036

Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-09-11	Hochstufung	Barclays	Equal Weight → Overweight
2025-08-19	Eingeleitet	William Blair	Outperform
2025-07-24	Herabstufung	HSBC Securities	Buy → Hold
2025-07-11	Hochstufung	Scotiabank	Sector Perform → Sector Outperform
2025-07-09	Herabstufung	UBS	Buy → Neutral
2025-01-10	Hochstufung	Bernstein	Mkt Perform → Outperform
2024-12-23	Eingeleitet	Scotiabank	Sector Perform
2024-10-14	Eingeleitet	Redburn Atlantic	Buy
2024-10-01	Eingeleitet	Stephens	Overweight
2024-08-28	Eingeleitet	Wells Fargo	Overweight
2024-06-03	Fortgesetzt	Jefferies	Buy
2024-03-18	Fortgesetzt	Citigroup	Neutral
2024-01-24	Herabstufung	Barclays	Overweight → Equal Weight
2024-01-08	Herabstufung	Bernstein	Outperform → Mkt Perform
2023-12-18	Eingeleitet	HSBC Securities	Buy
2023-12-13	Eingeleitet	Wolfe Research	Outperform
2023-10-26	Herabstufung	KeyBanc Capital Markets	Overweight → Sector Weight
2023-10-25	Hochstufung	Wells Fargo	Underweight → Equal Weight
2023-09-28	Eingeleitet	Bernstein	Outperform
2023-09-06	Fortgesetzt	Citigroup	Buy
2023-07-19	Eingeleitet	Raymond James	Outperform
2023-07-19	Bestätigt	Robert W. Baird	Outperform
2023-07-13	Hochstufung	Credit Suisse	Neutral → Outperform
2023-04-04	Bestätigt	Barclays	Overweight
2022-12-14	Eingeleitet	Deutsche Bank	Buy
2022-12-07	Eingeleitet	RBC Capital Mkts	Outperform
2022-10-27	Herabstufung	The Benchmark Company	Buy → Hold
2022-08-25	Eingeleitet	Credit Suisse	Neutral
2022-04-25	Herabstufung	Wells Fargo	Equal Weight → Underweight
2022-01-26	Fortgesetzt	Barclays	Overweight
2021-10-20	Hochstufung	Citigroup	Neutral → Buy
2021-10-15	Fortgesetzt	Cowen	Outperform
2021-08-05	Fortgesetzt	Credit Suisse	Outperform
2021-07-16	Eingeleitet	The Benchmark Company	Buy
2021-03-18	Hochstufung	KeyBanc Capital Markets	Sector Weight → Overweight
2021-03-03	Eingeleitet	Barclays	Overweight
2021-01-08	Hochstufung	Credit Suisse	Neutral → Outperform
2020-12-16	Herabstufung	Citigroup	Buy → Neutral
2020-12-02	Eingeleitet	Goldman	Buy
2020-11-10	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2020-09-30	Eingeleitet	Atlantic Equities	Overweight
2020-09-14	Eingeleitet	Morgan Stanley	Overweight
2020-08-20	Fortgesetzt	JP Morgan	Overweight
2020-07-15	Hochstufung	Cleveland Research	Neutral → Buy
2020-07-07	Bestätigt	Needham	Buy
2020-04-23	Bestätigt	Needham	Buy
2020-01-31	Bestätigt	Needham	Buy
2020-01-22	Eingeleitet	Credit Suisse	Neutral
2020-01-08	Eingeleitet	Wells Fargo	Equal Weight
2020-01-07	Eingeleitet	Citigroup	Buy
2019-11-15	Eingeleitet	Stifel	Buy
2019-07-25	Bestätigt	Needham	Buy
2019-07-16	Herabstufung	Needham	Strong Buy → Buy
2019-05-30	Eingeleitet	Wolfe Research	Outperform
2019-05-23	Bestätigt	Needham	Strong Buy
2019-04-22	Bestätigt	Needham	Strong Buy
2019-04-16	Bestätigt	BofA/Merrill	Buy

Alle ansehen

Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten

08:44 AM

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR - News-Medical

08:44 AM

08:23 AM

TD Cowen Adjusts Price Target on Thermo Fisher Scientific to $612 From $550, Maintains Buy Rating - MarketScreener

08:23 AM

Oct 13, 2025

Dr. Park CDMO Selects Thermo Fisher Scientific To Equip New Viral Vector Manufacturing Facility - Technology Networks

Oct 13, 2025

Franklin Street Loads Up on Thermo Fisher Scientific (NASDAQ:TMO): Becomes 8th Largest Holding - The Motley Fool

Oct 13, 2025

Understanding Thermo Fisher Scientific Inc.’s price movementEarnings Recap Report & Verified Chart Pattern Trade Signals - newser.com

Oct 13, 2025

Leerink Partners Adjusts Thermo Fisher Scientific Price Target to $545 From $500, Maintains Outperform Rating - MarketScreener

Oct 13, 2025

Yousif Capital Management LLC Lowers Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat

Oct 13, 2025

Single-cell Analysis Market to Reach USD 12.29 Billion by 2032, Driven by Expanding Oncology Research and Advanced Genomics – SNS Insider - GlobeNewswire Inc.

Oct 13, 2025

Published on: 2025-10-13 01:13:44 - newser.com

Oct 13, 2025

Oct 12, 2025

Thermo Fisher Scientific Completes $2.5 Billion Senior Notes Offering - Global Legal Chronicle

Oct 12, 2025

Thermo Fisher Scientific Inc. stock chart pattern explained2025 Winners & Losers & High Win Rate Trade Tips - newser.com

Oct 12, 2025

Estimating The Intrinsic Value Of Thermo Fisher Scientific Inc. (NYSE:TMO) - Yahoo Finance

Oct 12, 2025